{ rtf1 ansi ansicpg1252 deff0 deflang1033{ fonttbl{ f0 fswiss fcharset0 Arial;}} { * generator Msftedit 5.41.15.1515;} viewkind4 uc1 pard f0 fs21 The Southern Division (SD) of the Cooperative Human Tissue Network (CHTN) at UAB has participated par enthusiastically and effectively in all CHTN cooperative operations since its inception. The policies and par guidelines that have been established have resulted in a dependable investigator source for a wide par range of expertly processed and well-characterized human tissues, with associated histopathologic and par demographic data, that continues to have a major impact on cancer research. With current advances in par cancer research and technology, there has been an increased demand for more sophisticated tissue par samples. To meet these demands, the SD proposes continuing its leading roles in:1) the design and par modernization of the CHTN's computerized data management system to support increased networking par of tissues and compatibility with caBIG; 2) publicizing the availability of human tissues to the research par community and promoting communication between the scientists receiving tissues and the CHTN; 3) par development of regulatory policies to include: positions on confidentiality and informed consent; par inclusion of guidelines for implementation of new and modified Federal regulations and best practices par for tissue resources; 4) guidelines to protect against biohazards involved in use of human tissues; 5) par facilitating development of tissue resource infrastructure at multiple institutions through outreach and par education; and 6) education of investigators regarding optimization of tissue requests. At the local level, par the SD proposes to continue focusing on providing reliable high-quality human research tissues par obtained under optimal conditions from surgical procedures and autopsies performed at UAB par associated hospitals and subcontractor institutions. In response to investigator requests, the SD has par already established these procedures and has allocated equipment and expertise to provide par preneoplastic lesions, aliquots of tissues frozen within 15 minutes of recovery, as well as par microdissection, tissue matrix arrays, mRNA/DNA samples, and clinical follow-up. In the current funding par cycle (2001-2006), the SD, which primarily serves researchers in the Southern United States but also par serves investigators throughout the US and Canada through networking, has provided over 35,000 par fresh, frozen and fixed human tissue specimens to over 500 investigators. In the next funding cycle, par consortium agreements with participating institutions will provide access to tissues from more than par 150,000 surgical procedures with a goal of supplying 50,000 samples. fs20 par par }

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA044968-18S2
Application #
7414656
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J2))
Program Officer
Rubinstein, Yaffa
Project Start
1987-01-01
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2008-03-31
Support Year
18
Fiscal Year
2007
Total Cost
$737,542
Indirect Cost
Name
University of Alabama Birmingham
Department
Pathology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Atherton, Daniel S; Sexton, Katherine C; Otali, Dennis et al. (2016) Factors Affecting the Use of Human Tissues in Biomedical Research: Implications in the Design and Operation of a Biorepository. Methods Mol Biol 1381:1-38
Otali, D; Fredenburgh, J; Oelschlager, D K et al. (2016) A standard tissue as a control for histochemical and immunohistochemical staining. Biotech Histochem 91:309-26
Grizzle, William E; Gunter, Elaine W; Sexton, Katherine C et al. (2015) Quality management of biorepositories. Biopreserv Biobank 13:183-94
Otali, Dennis; He, Qinghua; Grizzle, William E (2013) The effect of antigen retrieval on cells fixed in 10% neutral buffered formalin followed by transfer to 70% ethanol. PLoS One 8:e82405
Bledsoe, Marianna J; Clayton, Ellen Wright; McGuire, Amy L et al. (2013) Return of research results from genomic biobanks: cost matters. Genet Med 15:103-5
Bledsoe, Marianna J; Grizzle, William E (2013) Use of human specimens in research: the evolving United States regulatory, policy, and scientific landscape. Diagn Histopathol (Oxf) 19:322-330
Otali, D; He, Q; Stockard, C R et al. (2013) Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol. Biotech Histochem 88:170-80
Grizzle, William E (2012) A Critical Need for Increased Understanding of the Use of Human Tissues in Biomedical Research. J Cancer Sci Ther 4:16-17
Bledsoe, Marianna J; Grizzle, William E; Clark, Brian J et al. (2012) Practical implementation issues and challenges for biobanks in the return of individual research results. Genet Med 14:478-83
Grizzle, William E; Knoppers, Bartha M; Zeps, Nikolajs et al. (2011) What are the most oppressing legal and ethical issues facing biorepositories and what are some strategies to address them? Biopreserv Biobank 9:317-9

Showing the most recent 10 out of 17 publications